Adiponectin stimulates RANKL and inhibits OPG expression in human osteoblasts through the MAPK signaling pathway

被引：290

作者：

Luo, Xiang-Hang ^{[1
]}

Guo, Li-Juan ^{[1
]}

Xie, Hui ^{[1
]}

Yuan, Ling-Qing ^{[1
]}

Wu, Xian-Ping ^{[1
]}

Zhou, Hou-De ^{[1
]}

Liao, Er-Yuan ^{[1
]}

机构：

[1] Cent S Univ, Xiangya Hosp 2, Inst Endocrinol & Metab, Changsha 410011, Hunan, Peoples R China

来源：

JOURNAL OF BONE AND MINERAL RESEARCH | 2006年 / 21卷 / 10期

关键词：

adiponectin; osteoblast; osteoclast; RANKL; osteoprotegerin;

D O I：

10.1359/JBMR.060707

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Our study indicates that recombinant adiponectin induced RANKL and inhibited OPG expression in human osteoblasts through the AdipoR1/p38 MAPK pathway, and these responses contributed to the adiponectin-induced osteoclasts formation in the co-culture of osteoblast and peripheral blood monocytes systems. These findings showed that adiponectin increased osteoclast formation indirectly through stimulating RANKL and inhibiting OPG production in osteoblasts. It also suggests the pharmacological nature of recombinant adiponectin that indirectly induces osteoclasts formation.

引用

页码：1648 / 1656

页数：9

共 36 条

[1] Osteoprotegerin and its ligand: A new paradigm for regulation of osteoclastogenesis and bone resorption [J].

Aubin, JE ;

Bonnelye, E .

OSTEOPOROSIS INTERNATIONAL, 2000, 11 (11) :905-913

[2] Adiponectin and its receptors are expressed in bone-forming cells [J].

Berner, HS ;

Lyngstadaas, SP ;

Spahr, A ;

Monjo, M ;

Thommesen, L ;

Drevon, CA ;

Syversen, U ;

Reseland, JE .

BONE, 2004, 35 (04) :842-849

[3] osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification [J].

Bucay, N ;

Sarosi, I ;

Dunstan, CR ;

Morony, S ;

Tarpley, J ;

Capparelli, C ;

Scully, S ;

Tan, HL ;

Xu, WL ;

Lacey, DL ;

Boyle, WJ ;

Simonet, WS .

GENES & DEVELOPMENT, 1998, 12 (09) :1260-1268

[4] Interleukin-6 (IL-6), IL-1, receptor activator of nuclear factor κB ligand (RANKL) and osteoprotegerin production by human osteoblastic cells:: comparison of the effects of 17-β oestradiol and raloxifene [J].

Cheung, J ;

Mak, YT ;

Papaioannou, S ;

Evans, BAJ ;

Fogelman, I ;

Hampson, G .

JOURNAL OF ENDOCRINOLOGY, 2003, 177 (03) :423-433

[5] Regulation of the osteoblast-specific transcription factor, runx2: Responsiveness to multiple signal transduction pathways [J].

Franceschi, RT ;

Xiao, GZ .

JOURNAL OF CELLULAR BIOCHEMISTRY, 2003, 88 (03) :446-454

[6] Role of receptor activator of nuclear factor-κB ligand and osteoprotegerin in bone cell biology [J].

Hofbauer, LC ;

Heufelder, AE .

JOURNAL OF MOLECULAR MEDICINE-JMM, 2001, 79 (5-6) :243-253

[7] Leptin inhibits osteoclast generation [J].

Holloway, WR ;

Collier, FM ;

Aitken, CJ ;

Myers, DE ;

Hodge, JM ;

Malakellis, M ;

Gough, TJ ;

Collier, GR ;

Nicholson, GC .

JOURNAL OF BONE AND MINERAL RESEARCH, 2002, 17 (02) :200-209

[8] Transforming growth factor-β induces expression of receptor activator of NF-κB ligand in vascular endothelial cells derived from bone [J].

Ishida, A ;

Fujita, N ;

Kitazawa, R ;

Tsuruo, T .

JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (29) :26217-26224

[9] Transforming growth factor-β induces osteoclast formation in the absence of RANKL [J].

Itonaga, I ;

Sabokbar, A ;

Sun, SG ;

Kudo, O ;

Danks, L ;

Ferguson, D ;

Fujikawa, Y ;

Athanasou, NA .

BONE, 2004, 34 (01) :57-64

[10] SEQUENTIAL PROTEIN-KINASE REACTIONS CONTROLLING CELL-GROWTH AND DIFFERENTIATION [J].

JOHNSON, GL ;

VAILLANCOURT, RR .

CURRENT OPINION IN CELL BIOLOGY, 1994, 6 (02) :230-238

← 1 2 3 4 →